Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Total Non-Current Liabilities (2016 - 2019)

Historic Total Non-Current Liabilities for Soleno Therapeutics (SLNO) over the last 7 years, with Q3 2019 value amounting to $7.8 million.

  • Soleno Therapeutics' Total Non-Current Liabilities fell 2906.29% to $7.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $7.8 million, marking a year-over-year decrease of 2906.29%. This contributed to the annual value of $7.1 million for FY2018, which is 47.73% down from last year.
  • Soleno Therapeutics' Total Non-Current Liabilities amounted to $7.8 million in Q3 2019, which was down 2906.29% from $14.3 million recorded in Q2 2019.
  • In the past 5 years, Soleno Therapeutics' Total Non-Current Liabilities ranged from a high of $20.3 million in Q1 2015 and a low of $2.0 million during Q3 2017
  • In the last 5 years, Soleno Therapeutics' Total Non-Current Liabilities had a median value of $4.9 million in 2015 and averaged $7.0 million.
  • Per our database at Business Quant, Soleno Therapeutics' Total Non-Current Liabilities plummeted by 9377.93% in 2015 and then surged by 51226.08% in 2018.
  • Soleno Therapeutics' Total Non-Current Liabilities (Quarter) stood at $4.9 million in 2015, then tumbled by 57.52% to $2.1 million in 2016, then soared by 244.45% to $7.1 million in 2017, then dropped by 0.48% to $7.1 million in 2018, then increased by 9.66% to $7.8 million in 2019.
  • Its Total Non-Current Liabilities stands at $7.8 million for Q3 2019, versus $14.3 million for Q2 2019 and $9.4 million for Q1 2019.